DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 01 · Volume 53 · Februar 2020 DOI: 10.1055/s-010-45471

Original Paper

  • 5
    Zheng, Wei; Li, Xian-Bin; Shi, Zhan-Ming; Yang, Xin-Hu; Cai, Dong-Bin; Ng, Chee H.; Ungvari, Gabor S.; Liu, Wei-Jian; Wu, Yu-Jie; Wang, Yuan-Yuan; Ning, Yu-Ping; Xiang, Yu-Tao:

    Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials

    Supplementary Material (PDF)
  • 21
    Schaefer, Martin; Sarkar, Susanne; Theophil, Ines; Leopold, Karolina; Heinz, Andreas; Gallinat, Jürgen:

    Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia

    Supporting Information (PDF)
  • 30
    Scherf-Clavel, Maike; Weidner, Anne; Deckert, Jürgen; Menke, Andreas; Unterecker, Stefan:

    Pathological Concentration of C-reactive Protein is Correlated to Increased Concentrations of Quetiapine, But Not of Risperidone, Olanzapine and Aripiprazole in a Naturalistic Setting

    • Review

  • 14
    Schönfeldt-Lecuona, Carlos; Cronemeyer, Maximilian; Hiesener, Lilli; Connemann, Bernhard J.; Gahr, Maximilian; Sartorius, Alexander; Mühlbauer, Viktoria:

    Comparison of International Therapy Guidelines with Regard to the Treatment of Malignant Catatonia

    • Letter to the Editor

  • 37
    Scherbaum, Norbert; Holzbach, Rüdiger; Stammen, Gunnar; Kirchof, Ute; Bonnet, Udo:

    Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany – Analysis of Data of A Statutory Health Insurance